These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7176218)

  • 21. Studies on the metabolism and biological activity of the epimers of sulindac.
    Brunell D; Sagher D; Kesaraju S; Brot N; Weissbach H
    Drug Metab Dispos; 2011 Jun; 39(6):1014-21. PubMed ID: 21383205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species differences in pulmonary N-oxidation of chlorpromazine and imipramine.
    Ohmiya Y; Mehendale HM
    Pharmacology; 1984; 28(5):289-95. PubMed ID: 6728903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of Sulindac.
    Kwan KC; Duggan DE
    Acta Rhumatol Belg; 1977; 1(3-4):168-78. PubMed ID: 756665
    [No Abstract]   [Full Text] [Related]  

  • 24. The metabolism of 4-substituted-N-ethyl-N-methyl-anilines. II. Some factors influencing alpha-C- and N-oxidation.
    Gorrod JW; Patterson LH
    Xenobiotica; 1983 Sep; 13(9):513-20. PubMed ID: 6659547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulindac oxidation/reduction by microbial cultures; microbial models of mammalian metabolism.
    Davis PJ; Guenthner LE
    Xenobiotica; 1985 Oct; 15(10):845-57. PubMed ID: 4072250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of graded oral doses of sulindac in man.
    Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
    Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S-oxidation of thioureylenes catalyzed by a microsomal flavoprotein mixed-function oxidase.
    Poulsen LL; Hyslop RM; Ziegler DM
    Biochem Pharmacol; 1974 Dec; 23(24):3431-40. PubMed ID: 4441423
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung explants.
    Bouchard L; Castonguay A
    Drug Metab Dispos; 1993; 21(2):293-8. PubMed ID: 8097699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enterohepatic circulation of sulindac and metabolites.
    Dujovne CA; Pitterman A; Vincek WC; Dobrinska MR; Davies RO; Duggan DE
    Clin Pharmacol Ther; 1983 Feb; 33(2):172-7. PubMed ID: 6822030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxygenase.
    Stefek M; Benes L; Zelník V
    Xenobiotica; 1989 Feb; 19(2):143-50. PubMed ID: 2728489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.
    Stubbs RJ; Ng LL; Entwistle LA; Bayne WF
    J Chromatogr; 1987 Jan; 413():171-80. PubMed ID: 3558666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interconversions of haloperidol and reduced haloperidol in guinea pig and rat liver microsomes.
    Korpi ER; Costakos DT; Wyatt RJ
    Biochem Pharmacol; 1985 Aug; 34(16):2923-7. PubMed ID: 4026878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disposition of sulindac.
    Duggan DE; Hare LE; Ditzler CA; Lei BW; Kwan KC
    Clin Pharmacol Ther; 1977 Mar; 21(3):326-35. PubMed ID: 300048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some factors involved in the N-oxidation of 3-substituted pyridines by microsomal preparations in vitro.
    Gorrod JW; Damani LA
    Xenobiotica; 1979 Apr; 9(4):209-18. PubMed ID: 483857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of microsomal enzyme systems that reduce N-hydroxyphentermine.
    Sum CY; Cho AK
    Drug Metab Dispos; 1976; 4(5):436-41. PubMed ID: 10142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfoxide reductase activity of liver aldehyde oxidase.
    Tatsumi K; Kitamura S; Yamada H
    Biochim Biophys Acta; 1983 Sep; 747(1-2):86-92. PubMed ID: 6688361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.
    Williams CS; Goldman AP; Sheng H; Morrow JD; DuBois RN
    Neoplasia; 1999 Jun; 1(2):170-6. PubMed ID: 10933052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfoxide reduction: in vitro reduction of oxyprothepine-8-sulfoxide by rat hepatic cytosolic and microsomal enzymes.
    Helia O; Pauliková I
    Pharmazie; 1993 Oct; 48(10):784-5. PubMed ID: 7903462
    [No Abstract]   [Full Text] [Related]  

  • 40. Microsomal N-hydroxylation of dibenzylamine.
    Beckett AH; Gibson GG
    Xenobiotica; 1975 Nov; 5(11):677-86. PubMed ID: 1189462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.